| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| D7LN67 | Tubulin beta-2; | TUB2; | XP_002877519.1; | 449 | Arabidopsis-lyrata |
| D7MV54 | Armadillo/beta-catenin repeat family protein; | NULL | XP_002866707.1; | 710 | Arabidopsis-lyrata |
| D7M228 | Putative uncharacterized protein; | NULL | XP_002873396.1; | 1118 | Arabidopsis-lyrata |
| D7KQT3 | Putative uncharacterized protein; | NULL | XP_002893414.1; | 1185 | Arabidopsis-lyrata |
| D7KN97 | Flavin-containing monooxygenase; EC 1.-.-.-; | NULL | XP_002889917.1; | 459 | Arabidopsis-lyrata |
| D7LF14 | Putative uncharacterized protein; | NULL | XP_002879406.1; | 220 | Arabidopsis-lyrata |
| D7L7C7 | Glutamate decarboxylase; EC 4.1.1.15; | NULL | XP_002885227.1; | 493 | Arabidopsis-lyrata |
| D7MBJ3 | Putative uncharacterized protein; | NULL | XP_002869347.1; | 187 | Arabidopsis-lyrata |
| D7LLL0 | Predicted protein; | NULL | XP_002880108.1; | 472 | Arabidopsis-lyrata |
| D7LLE7 | Peptidyl-prolyl cis-trans isomerase; EC 5.2.1.8; | NULL | XP_002881077.1; | 201 | Arabidopsis-lyrata |
| D7LZE9 | NADH-cytochrome b5 reductase; EC 1.6.2.2; | NULL | XP_002871921.1; | 328 | Arabidopsis-lyrata |
| D7LIC2 | Glutamate receptor; | NULL | XP_002880611.1; | 841 | Arabidopsis-lyrata |
| D7MSQ3 | Senescence-associated gene 12; | SAG12; | XP_002865220.1; | 346 | Arabidopsis-lyrata |
| D7KB68 | Translocase of chloroplast; EC 3.6.5.-; | NULL | XP_002892097.1; | 297 | Arabidopsis-lyrata |
| D7MNJ9 | Flavin-containing monooxygenase; EC 1.-.-.-; | NULL | XP_002863626.1; | 425 | Arabidopsis-lyrata |
| D7MVT6 | Predicted protein; Fragment; | NULL | XP_002863082.1; | 517 | Arabidopsis-lyrata |
| D7MQC9 | Putative uncharacterized protein; | NULL | XP_002866262.1; | 142 | Arabidopsis-lyrata |
| D7LFK9 | Purple acid phosphatase; EC 3.1.3.2; | NULL | XP_002879414.1; | 538 | Arabidopsis-lyrata |
| D7LV37 | Ubiquitin-conjugating enzyme 14; | UBC14; | XP_002876298.1; | 167 | Arabidopsis-lyrata |
| D7LUF5 | Pectate lyase; EC 4.2.2.2; | NULL | XP_002876192.1; | 484 | Arabidopsis-lyrata |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |